Breakdown | ||||
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
46.52B | 59.82B | 54.11B | 48.16B | 47.70B | Gross Profit |
4.58B | 5.80B | 5.08B | 4.32B | 3.83B | EBIT |
2.67B | 3.82B | 3.14B | 2.43B | 1.90B | EBITDA |
4.73B | 5.49B | 4.92B | 4.28B | 3.68B | Net Income Common Stockholders |
2.05B | 2.70B | 2.26B | 1.75B | 1.42B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
9.42B | 9.31B | 7.10B | 5.94B | 4.64B | Total Assets |
49.50B | 44.44B | 41.99B | 42.54B | 41.54B | Total Debt |
9.10B | 9.66B | 10.42B | 12.30B | 13.36B | Net Debt |
-324.00M | 355.00M | 3.32B | 6.37B | 8.72B | Total Liabilities |
21.27B | 19.98B | 20.50B | 22.87B | 23.37B | Stockholders Equity |
28.23B | 24.46B | 21.49B | 19.67B | 18.17B |
Cash Flow | Free Cash Flow | |||
1.41B | 3.36B | 3.52B | 2.90B | 2.75B | Operating Cash Flow |
3.91B | 5.24B | 4.52B | 3.69B | 3.63B | Investing Cash Flow |
-2.67B | -2.01B | -784.00M | -612.00M | -1.03B | Financing Cash Flow |
-1.38B | -1.23B | -2.45B | -1.68B | -1.27B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | $1.72T | 4.31 | 15.47% | 4.05% | 6.27% | 19.66% | |
74 Outperform | ¥3.49T | 9.01 | 14.33% | 2.12% | 14.46% | 62.35% | |
71 Outperform | $1.03T | 9.73 | 9.29% | 4.10% | 6.68% | -32.72% | |
70 Outperform | $562.46B | 11.68 | 7.02% | 3.08% | -3.53% | 21.38% | |
69 Neutral | ¥14.70B | 6.46 | 3.11% | 4.24% | 14.03% | ||
68 Neutral | ¥201.32B | 14.11 | 6.34% | 6.23% | 0.40% | ― | |
64 Neutral | $4.28B | 11.80 | 5.33% | 250.46% | 4.10% | -9.26% |